{"id":47289,"date":"2024-12-20T11:00:43","date_gmt":"2024-12-20T11:00:43","guid":{"rendered":"https:\/\/ibima.eu\/manuel-cobo-dols\/"},"modified":"2026-01-06T13:50:24","modified_gmt":"2026-01-06T13:50:24","slug":"manuel-cobo-dols","status":"publish","type":"post","link":"https:\/\/ibima.eu\/en\/manuel-cobo-dols\/","title":{"rendered":"MANUEL COBO DOLS"},"content":{"rendered":"<p>Research profile: R4<\/p>\n<h4 data-start=\"314\" data-end=\"511\"><strong data-start=\"314\" data-end=\"355\"><span class=\"hover:entity-accent entity-underline inline cursor-pointer align-baseline\"><span class=\"whitespace-normal\">Manuel Cobo Dols<\/span><\/span><\/strong> es <strong data-start=\"359\" data-end=\"387\">Researcher in Charge<\/strong> from <strong data-start=\"392\" data-end=\"451\">grupo B-22 \u201c<a href=\"https:\/\/ibima.eu\/en\/project\/b-22\/page\/3\/?et_blog\">Terapias Emergentes Antiadaptaci\u00f3n Tumoral<\/a>\u201d<\/strong> del Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga \u2013 IBIMA.<\/h4>\n<p data-start=\"513\" data-end=\"727\">Es <strong data-start=\"516\" data-end=\"559\">m\u00e9dico especialista en Oncolog\u00eda M\u00e9dica<\/strong>, con una trayectoria consolidada en <strong data-start=\"596\" data-end=\"646\">investigaci\u00f3n cl\u00ednica y traslacional en c\u00e1ncer<\/strong>, especialmente en <strong data-start=\"665\" data-end=\"685\">c\u00e1ncer de pulm\u00f3n<\/strong> and <strong data-start=\"688\" data-end=\"726\">terapias dirigidas e inmunoterapia<\/strong>.<\/p>\n<p data-start=\"729\" data-end=\"1045\">Desarrolla su actividad investigadora en <strong data-start=\"770\" data-end=\"798\">IBIMA BIONAND Platform<\/strong>, donde participa de forma continuada en proyectos competitivos y ensayos cl\u00ednicos internacionales desde 1999. Ha formado parte de m\u00faltiples grupos de <strong data-start=\"949\" data-end=\"992\">oncolog\u00eda traslacional multidisciplinar<\/strong>, colaborando con redes nacionales e internacionales.<\/p>\n<p data-start=\"1047\" data-end=\"1289\">Su investigaci\u00f3n se centra en la <strong data-start=\"1080\" data-end=\"1115\">identificaci\u00f3n de biomarcadores<\/strong>, la <strong data-start=\"1120\" data-end=\"1139\">biopsia l\u00edquida<\/strong>, la <strong data-start=\"1144\" data-end=\"1169\">integraci\u00f3n de \u00f3micas<\/strong>, y el desarrollo de <strong data-start=\"1190\" data-end=\"1233\">estrategias terap\u00e9uticas personalizadas<\/strong> para superar los mecanismos de <strong data-start=\"1265\" data-end=\"1288\">resistencia tumoral<\/strong>.<\/p>\n<p data-start=\"1291\" data-end=\"1598\">Ha sido <strong data-start=\"1299\" data-end=\"1325\">Investigador Principal<\/strong> en proyectos financiados por el <strong data-start=\"1358\" data-end=\"1391\">Carlos III Health Institute<\/strong> y otras entidades competitivas, as\u00ed como investigador en numerosos <strong data-start=\"1459\" data-end=\"1496\">ensayos cl\u00ednicos fase I, II y III<\/strong> en oncolog\u00eda m\u00e9dica, liderando estudios en inmunoterapia, terapias dirigidas y medicina de precisi\u00f3n.<\/p>\n<p data-start=\"1600\" data-end=\"1858\">Cuenta con una amplia experiencia en <strong data-start=\"1637\" data-end=\"1671\">investigaci\u00f3n cl\u00ednica aplicada<\/strong>, con participaci\u00f3n activa en estudios promovidos por sociedades cient\u00edficas y la industria farmac\u00e9utica internacional, especialmente en el \u00e1mbito del <strong data-start=\"1822\" data-end=\"1857\">c\u00e1ncer de pulm\u00f3n no microc\u00edtico<\/strong>.<\/p>\n<p data-start=\"1860\" data-end=\"1997\">Ha desarrollado tambi\u00e9n actividad <strong data-start=\"1894\" data-end=\"1919\">docente universitaria<\/strong> en Medicina, vinculada a asignaturas de patolog\u00eda m\u00e9dica y oncolog\u00eda cl\u00ednica.<\/p>\n<p data-start=\"1999\" data-end=\"2234\">Su perfil combina <strong data-start=\"2017\" data-end=\"2039\">asistencia cl\u00ednica<\/strong>, <strong data-start=\"2041\" data-end=\"2071\">investigaci\u00f3n traslacional<\/strong>, <strong data-start=\"2073\" data-end=\"2106\">liderazgo en ensayos cl\u00ednicos<\/strong> and <strong data-start=\"2109\" data-end=\"2143\">transferencia del conocimiento<\/strong>, contribuyendo al avance de nuevas terapias antitumorales basadas en evidencia cient\u00edfica.<\/p>\n<p data-start=\"2236\" data-end=\"2275\"><strong data-start=\"2236\" data-end=\"2249\">Contact:<\/strong> <a class=\"decorated-link cursor-pointer\" rel=\"noopener\" data-start=\"2250\" data-end=\"2273\">manuelcobodols@yahoo.es<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Perfil investigador\/a: R4 Manuel Cobo Dols es Investigador Responsable del grupo B-22 \u201cTerapias Emergentes Antiadaptaci\u00f3n Tumoral\u201d del Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga \u2013 IBIMA. Es m\u00e9dico especialista en Oncolog\u00eda M\u00e9dica, con una trayectoria consolidada en investigaci\u00f3n cl\u00ednica y traslacional en c\u00e1ncer, especialmente en c\u00e1ncer de pulm\u00f3n y terapias dirigidas e inmunoterapia. Desarrolla su actividad [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":49765,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[2641],"tags":[3210,3207,2747,3208],"class_list":["post-47289","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-investigador-responsable-b-22","tag-antiadaptacion","tag-b-22","tag-ibima","tag-terapias-emergentes"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>MANUEL COBO DOLS - Ibima<\/title>\n<meta name=\"description\" content=\"Manuel Cobo Dols es investigador responsable del grupo de IBIMA Terapias Emergentes antiadaptaci\u00f3n tumoral (B-22)\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ibima.eu\/en\/manuel-cobo-dols\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MANUEL COBO DOLS - Ibima\" \/>\n<meta property=\"og:description\" content=\"Manuel Cobo Dols es investigador responsable del grupo de IBIMA Terapias Emergentes antiadaptaci\u00f3n tumoral (B-22)\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ibima.eu\/en\/manuel-cobo-dols\/\" \/>\n<meta property=\"og:site_name\" content=\"Ibima\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-20T11:00:43+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-06T13:50:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/12\/Manolo-cobo.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1530\" \/>\n\t<meta property=\"og:image:height\" content=\"1611\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"prodriguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"prodriguez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/manuel-cobo-dols\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/manuel-cobo-dols\\\/\"},\"author\":{\"name\":\"prodriguez\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/40b410344dd5ad2315bb651e3fbfa635\"},\"headline\":\"MANUEL COBO DOLS\",\"datePublished\":\"2024-12-20T11:00:43+00:00\",\"dateModified\":\"2026-01-06T13:50:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/manuel-cobo-dols\\\/\"},\"wordCount\":286,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/manuel-cobo-dols\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ibima.eu\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/Manolo-cobo.jpeg\",\"keywords\":[\"antiadaptacion\",\"b-22\",\"IBIMA\",\"terapias emergentes\"],\"articleSection\":[\"Investigador Responsable - B-22\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/ibima.eu\\\/manuel-cobo-dols\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/manuel-cobo-dols\\\/\",\"url\":\"https:\\\/\\\/ibima.eu\\\/manuel-cobo-dols\\\/\",\"name\":\"MANUEL COBO DOLS - Ibima\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/manuel-cobo-dols\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/manuel-cobo-dols\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ibima.eu\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/Manolo-cobo.jpeg\",\"datePublished\":\"2024-12-20T11:00:43+00:00\",\"dateModified\":\"2026-01-06T13:50:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/40b410344dd5ad2315bb651e3fbfa635\"},\"description\":\"Manuel Cobo Dols es investigador responsable del grupo de IBIMA Terapias Emergentes antiadaptaci\u00f3n tumoral (B-22)\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/manuel-cobo-dols\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ibima.eu\\\/manuel-cobo-dols\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/manuel-cobo-dols\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ibima.eu\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/Manolo-cobo.jpeg\",\"contentUrl\":\"https:\\\/\\\/ibima.eu\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/Manolo-cobo.jpeg\",\"width\":1530,\"height\":1611,\"caption\":\"Manolo cobo\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/manuel-cobo-dols\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MANUEL COBO DOLS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\",\"name\":\"Ibima\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ibima.eu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/40b410344dd5ad2315bb651e3fbfa635\",\"name\":\"prodriguez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g\",\"caption\":\"prodriguez\"},\"sameAs\":[\"https:\\\/\\\/ibima.eu\"],\"url\":\"https:\\\/\\\/ibima.eu\\\/en\\\/author\\\/prodriguez\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MANUEL COBO DOLS - Ibima","description":"Manuel Cobo Dols es investigador responsable del grupo de IBIMA Terapias Emergentes antiadaptaci\u00f3n tumoral (B-22)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ibima.eu\/en\/manuel-cobo-dols\/","og_locale":"en_GB","og_type":"article","og_title":"MANUEL COBO DOLS - Ibima","og_description":"Manuel Cobo Dols es investigador responsable del grupo de IBIMA Terapias Emergentes antiadaptaci\u00f3n tumoral (B-22)","og_url":"https:\/\/ibima.eu\/en\/manuel-cobo-dols\/","og_site_name":"Ibima","article_published_time":"2024-12-20T11:00:43+00:00","article_modified_time":"2026-01-06T13:50:24+00:00","og_image":[{"width":1530,"height":1611,"url":"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/12\/Manolo-cobo.jpeg","type":"image\/jpeg"}],"author":"prodriguez","twitter_card":"summary_large_image","twitter_misc":{"Written by":"prodriguez","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ibima.eu\/manuel-cobo-dols\/#article","isPartOf":{"@id":"https:\/\/ibima.eu\/manuel-cobo-dols\/"},"author":{"name":"prodriguez","@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635"},"headline":"MANUEL COBO DOLS","datePublished":"2024-12-20T11:00:43+00:00","dateModified":"2026-01-06T13:50:24+00:00","mainEntityOfPage":{"@id":"https:\/\/ibima.eu\/manuel-cobo-dols\/"},"wordCount":286,"commentCount":0,"image":{"@id":"https:\/\/ibima.eu\/manuel-cobo-dols\/#primaryimage"},"thumbnailUrl":"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/12\/Manolo-cobo.jpeg","keywords":["antiadaptacion","b-22","IBIMA","terapias emergentes"],"articleSection":["Investigador Responsable - B-22"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ibima.eu\/manuel-cobo-dols\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ibima.eu\/manuel-cobo-dols\/","url":"https:\/\/ibima.eu\/manuel-cobo-dols\/","name":"MANUEL COBO DOLS - Ibima","isPartOf":{"@id":"https:\/\/ibima.eu\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ibima.eu\/manuel-cobo-dols\/#primaryimage"},"image":{"@id":"https:\/\/ibima.eu\/manuel-cobo-dols\/#primaryimage"},"thumbnailUrl":"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/12\/Manolo-cobo.jpeg","datePublished":"2024-12-20T11:00:43+00:00","dateModified":"2026-01-06T13:50:24+00:00","author":{"@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635"},"description":"Manuel Cobo Dols es investigador responsable del grupo de IBIMA Terapias Emergentes antiadaptaci\u00f3n tumoral (B-22)","breadcrumb":{"@id":"https:\/\/ibima.eu\/manuel-cobo-dols\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ibima.eu\/manuel-cobo-dols\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ibima.eu\/manuel-cobo-dols\/#primaryimage","url":"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/12\/Manolo-cobo.jpeg","contentUrl":"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/12\/Manolo-cobo.jpeg","width":1530,"height":1611,"caption":"Manolo cobo"},{"@type":"BreadcrumbList","@id":"https:\/\/ibima.eu\/manuel-cobo-dols\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/ibima.eu\/es\/"},{"@type":"ListItem","position":2,"name":"MANUEL COBO DOLS"}]},{"@type":"WebSite","@id":"https:\/\/ibima.eu\/es\/#website","url":"https:\/\/ibima.eu\/es\/","name":"Ibima","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ibima.eu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635","name":"prodriguez","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g","caption":"prodriguez"},"sameAs":["https:\/\/ibima.eu"],"url":"https:\/\/ibima.eu\/en\/author\/prodriguez\/"}]}},"_links":{"self":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/posts\/47289","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/comments?post=47289"}],"version-history":[{"count":2,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/posts\/47289\/revisions"}],"predecessor-version":[{"id":59347,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/posts\/47289\/revisions\/59347"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/media\/49765"}],"wp:attachment":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/media?parent=47289"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/categories?post=47289"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/tags?post=47289"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}